Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) rose 4.9% during trading on Monday . The company traded as high as GBX 1.60 and last traded at GBX 1.60. 797,842 shares traded hands during trading, a decline of 51% from the average daily volume of 1,624,836 shares. The stock had previously closed at GBX 1.52.
Cizzle Biotechnology Price Performance
The stock has a market capitalization of £6.80 million, a PE ratio of -9.41 and a beta of 0.02. The stock’s fifty day moving average is GBX 2.14 and its 200-day moving average is GBX 2.22.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than Cizzle Biotechnology
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
